Human birth tissue material composition and methods for the treatment of damage associated with a cerebral vascular accident
Methods of treating vascular damage caused by a cerebral vascular accident in a subject are provided. The method includes the step of administering an effective amount of a human birth tissue material composition to a damaged site in a brain.
1. A method of treating vascular damage caused by a cerebral vascular accident in an individual suffering therefrom, comprising:
administering an effective amount of a human birth tissue material composition to a damaged vascular site in the brain of said individual, the human birth tissue material composition comprising one or more morselized placental organ components homogenized with an amniotic fluid composition, wherein each of the one or more placental components is selected from the group consisting of umbilical cord, chorionic membrane, amnion membrane, amniotic membrane, and Wharton's jelly.
2. The method of claim 1 , wherein the step of administering the human birth tissue material composition includes introducing the human birth tissue material composition directly onto or into the damaged site.
3. The method of claim 1 , wherein the step of administering the human birth tissue material composition includes introducing the human birth tissue material composition to the damaged site via a blood vessel.
4. The method of claim 3 , wherein the step of introducing the human birth tissue material composition to the damaged site includes injecting the human birth tissue material composition into at least one artery.
5. The method of claim 4 , wherein the artery is located in the neck, leg, arm, or groin.
6. The method of claim 3 , wherein the step of introducing the human birth tissue material composition to the damaged site includes delivering the human birth tissue material composition with the assistance of a catheter.
7. The method of claim 6 , wherein the catheter is inserted in the neck, leg, arm, or groin.
8. The method of claim 1 , wherein the amniotic fluid composition comprises amniotic fluid and human albumin 25% solution.